Insulin receptor substrate protein p53 localization in rats suggests mechanism for specific polyglutamine neurodegeneration

Neuroscience Letters

Volumn 309, Issue 3, 2001, Pages 145-148

  Thomas, Elizabeth A ^a   Foye, Pamela E ^a   Alvarez, Carlos E ^a   Usui, Hiroshi ^a   Gregor Sutcliffe, J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cortex; Dentatorubral pallidoluysian atrophy; Expression; In situ hybridization; Insulin receptor substrate; Neurodegeneration; Polyglutamine; Striatum

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; INSULIN; INSULIN RECEPTOR KINASE; INSULIN RECEPTOR SUBSTRATE PROTEIN P53; POLYGLUTAMINE; PROTEIN P53; SOMATOMEDIN; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DENTATORUBROPALLIDOLUYSIAN ATROPHY; FOREBRAIN; GENE EXPRESSION; GENETIC CODE; HIPPOCAMPUS; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; MOLECULAR CLONING; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; OLFACTORY BULB; PONS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CEREBRAL CORTEX; CORPUS STRIATUM; HUMANS; MALE; MICE; MYOCLONIC EPILEPSIES, PROGRESSIVE; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0035979811     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)02064-X     Document Type: Article

References (20)

1. The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses
2. Intranuclear inclusions in DRPLA
3. A cortical neuropeptide with neuronal depressant and sleep-modulating properties
4. Insulin receptor substrate (IRS) transduction system: Distinct and overlapping signaling potential
5. Hereditary dentatorubral-pallidoluysian atrophy: Detection of widespread ubiquinated neuronal and glial intracellular inclusions in the brain
6. Expression and distribution of the dentatorubral-pallidoluysian atrophy gene product (atrophin-1/drplap) in neuronal and non-neuronal tissues
7. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA)
8. Activation of MLK2-mediated signaling cascades by polyglutamine-expanded huntingtin
9. SH3 domain-dependent association of huntingtin with epidermal growth factor receptor signaling complexes
10. Human, dentatorubral-pallidoluysian atrophy protein interacts through a proline-rich region near polyglutamine with the SH3 domain of an insulin receptor tyrosine kinase substrate
11. Insulin-like growth factor-I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase
12. Huntington's disease and dentatorubral-pallidoluysian atrophy: Proteins, pathogenesis and pathology
13. Insulin receptors and insulin action in the brain: Review and clinical implications
14. Hereditary dentatorubral-pallidoluysian atrophy: Clinical and pathologic variants in a family
15. Huntington's disease: The challenge for cell biologists
16. Isolation of clones of rat striatum-specific mRNAs by directional tag PCR subtraction
17. Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins
18. Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription
19. Abnormal gene product identified in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) brain
20. Glutamine repeats and neurodegeneration